Can Cannabis Prevent Dyskinesia in Long-Term Treatment of Parkinson’s Disease?

In 1970, Oliver Sacks wrote five letters to various medical journals in the U.S. expressing his concern about the prescription drug levodopa, which had been developed just a year earlier. As a practicing neurologist, he had used levodopa (L-Dopa) to treat Parkinson’s and encephalitis lethargica (or “sleepy-sickness”) in his patients—both neurological disorders that arise from […]

Continue Reading

The Future of Designer Cannabis: Interview with Josh of Level Blends

Cannabis is big news these days—with state legalization initiatives and expanding mainstream cultural acceptance—but what many don’t realize is that our scientific understanding of this plant and our ability to harness its full potential is still in its infancy. One company that is setting out to improve our understanding of cannabis is Level Blends, a […]

Continue Reading